|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows from Operating Activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Stock-based compensation expense | |||||
| Unrealized foreign exchange loss | |||||
| Amortization of intangible assets | |||||
| Amortization of right of use asset | |||||
| Depreciation and amortization of property and equipment | |||||
| Deferred tax (benefit) expense | |||||
| Excess and obsolescence reserve | |||||
| Accretion of discounts and premiums on investments | |||||
| Impairment of long-lived assets | |||||
| Loss on asset disposals | |||||
| Gain on derecognition of lease assets and liabilities | |||||
| Changes in assets and liabilities: | |||||
| Prepaid expenses, other assets and long-term assets | |||||
| Trade accounts receivable | |||||
| Inventory | |||||
| Operating lease liabilities | |||||
| Accounts payable | |||||
| Accrued expenses and other liabilities | |||||
| Net cash used in operating activities | |||||
| Cash Flows from Investing Activities | |||||
| Maturities of investments | |||||
| Purchase of investments | |||||
| Cash paid for acquisition, net of cash acquired | |||||
| Cash paid for acquisition, including contingent consideration, net of cash acquired | |||||
| Purchase of property and equipment | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash Flows from Financing Activities | |||||
| Tax payments related to shares withheld for vested restricted stock units | |||||
| Proceeds from the issuance of common stock under employee stock purchase plan | |||||
| Proceeds from the issuance of common stock upon exercise of options | |||||
| Proceeds from the issuance of common stock, net | |||||
| Net cash provided by financing activities | |||||
| Effect of foreign exchange rate changes | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, Cash Equivalents and Restricted Cash Beginning of Period | |||||
| Cash, Cash Equivalents and Restricted Cash End of Period | |||||
| Supplemental disclosure of non-cash investing and financing activities: | |||||
| Fair value of net assets acquired | |||||
| Net unrealized loss on investments | |||||
| Acquisition of property and equipment included in accounts payable and accrued expenses | |||||
| Intangible asset and deferred tax liability arising from contingent consideration | |||||
| Conversion of convertible preferred stock to common stock | |||||
| Lease liabilities arising from obtaining right-of-use asset from new leases | |||||
| Increase / (decrease) in lease liabilities due to obtaining/(reduction in) right-of-use assets from lease modifications | |||||
Loading...